Clinical Outcomes of Impella Microaxial Devices Used to Salvage Cardiogenic Shock as a Bridge to Durable Circulatory Support or Cardiac Transplantation

被引:27
作者
Cheng, Richard [1 ]
Tank, Rikin [2 ]
Ramzy, Danny [3 ]
Azarbal, Babak [1 ]
Chung, Joshua [3 ]
Esmailian, Fardad [3 ]
Kobashigawa, Jon A. [1 ]
Moriguchi, Jaime D. [1 ]
Arabia, Francisco A. [3 ]
机构
[1] Cedars Sinai Heart Inst, Div Cardiol, 127 S San Vicente Blvd,Suite A3308, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA
[3] Cedars Sinai Heart Inst, Div Cardiothorac Surg, Los Angeles, CA USA
关键词
Impella; severe cardiogenic shock; percutaneous temporary circulatory support; mechanical circulatory support; bridge to decision and transplantation; EXTRACORPOREAL MEMBRANE-OXYGENATION; HEART-TRANSPLANTATION; ARTERY; METAANALYSIS; REMOVAL; ARREST;
D O I
10.1097/MAT.0000000000000877
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Temporary mechanical circulatory support (MCS) can be a bridge to decision for patients in severe cardiogenic shock who may be eligible for durable support or transplantation. Outcomes with Impella microaxial devices for salvage of severe shock in the end-stage heart failure population are not well described. Patients who underwent Impella placement as a bridge to decision, durable MCS, or transplantation were included. Eighty Impella devices (2.5 [1.3%], CP [53.8%], and 5.0 [45.0%]) were placed in 64 patients. Implant age was 56.2 +/- 12.5 years. Mean duration of assisted support was 13.2 +/- 15.1 days, and median duration per device was 7 days (interquartile range: 3-14). A total of 48.4% were in Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS 1) shock at implant, 51.6% in profile 2. Recent cardiopulmonary resuscitation (CPR) (26.7%), ventilator use (67.2%), and extracorporeal membrane oxygenation (ECMO) use (26.7%) were frequent. Forty four of sixty four (68.8%) survived to next therapy: durable MCS (40.9%), heart transplant (OHT) (36.4%), and recovery (22.7%). Overall 30 and 60 day survival were 67.2% and 65.6%, respectively. Thirty and 60 day survival conditional on having survived to next therapy were 94.1% and 91.2%, respectively. Survivors were less likely to be on ventilators (p = 0.049) or continuous renal replacement therapy (p < 0.001) but were otherwise not different from nonsurvivors by age, sex, INTERMACS profile, CPR, prevalence of ischemic cardiomyopathy, among other characteristics. Sixteen patients were directly bridged to heart transplantation, and all were alive at long-term follow-up. Impella devices can be used to salvage patients in severe heart failure as a bridge to decision, durable MCS, or transplantation. Baseline demographics are not predictive of survival. Their use for this indication is increasing and further investigations are warranted.
引用
收藏
页码:642 / 648
页数:7
相关论文
共 18 条
[1]   Current Status of Percutaneous Right Ventricular Assist Devices: First-In-Man Use of a Novel Dual Lumen Cannula [J].
Aggarwal, Vikas ;
Einhorn, Bryce N. ;
Cohen, Howard A. .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 88 (03) :390-396
[2]   Incidence of Hemolysis in Patients with Cardiogenic Shock Treated with Impella Percutaneous Left Ventricular Assist Device [J].
Badiye, Amit P. ;
Hernandez, Gabriel A. ;
Novoa, Italo ;
Chaparro, Sandra V. .
ASAIO JOURNAL, 2016, 62 (01) :11-14
[3]  
Bansal A, 2016, OCHSNER J, V16, P210
[4]   Device Strategies for Patients in INTERMACS Profiles 1 and 2 Cardiogenic Shock: Double Bridge With Extracorporeal Membrane Oxygenation and Initial Implant of More Durable Devices [J].
Cheng, Richard ;
Ramzy, Danny ;
Azarbal, Babak ;
Arabia, Francisco A. ;
Esmailian, Fardad ;
Czer, Lawrence S. ;
Kobashigawa, Jon A. ;
Moriguchi, Jaime D. .
ARTIFICIAL ORGANS, 2017, 41 (03) :224-232
[5]   Complications of Extracorporeal Membrane Oxygenation for Treatment of Cardiogenic Shock and Cardiac Arrest: A Meta-Analysis of 1,866 Adult Patients [J].
Cheng, Richard ;
Hachamovitch, Rory ;
Kittleson, Michelle ;
Patel, Jignesh ;
Arabia, Francisco ;
Moriguchi, Jaime ;
Esmailian, Fardad ;
Azarbal, Babak .
ANNALS OF THORACIC SURGERY, 2014, 97 (02) :610-616
[6]   Temporary Left Ventricular Assist Device Through an Axillary Access is a Promising Approach to Improve Outcomes in Refractory Cardiogenic Shock Patients [J].
Doersch, Karen M. ;
Tong, Carl W. ;
Gongora, Enrique ;
Konda, Subbareddy ;
Sareyyupoglu, Basar .
ASAIO JOURNAL, 2015, 61 (03) :253-258
[7]   Extracorporeal membrane oxygenation as a direct bridge to heart transplantation in adults [J].
Fukuhara, Shinichi ;
Takeda, Koji ;
Kurlansky, Paul A. ;
Naka, Yoshifumi ;
Takayama, Hiroo .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (04) :1607-+
[8]   Use of a percutaneous temporary circulatory support device as a bridge to decision during acute decompensation of advanced heart failure [J].
Hall, Shelley A. ;
Uriel, Nir ;
Carey, Sandra A. ;
Edens, Michelle ;
Gong, Geoffrey ;
Esposito, Michele ;
O'Kelly, Ryan ;
Annamalai, Shiva ;
Aghili, Nima ;
Adatya, S. ;
Kapur, Navin K. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (01) :100-106
[9]   Seventh INTERMACS annual report: 15,000 patients and counting [J].
Kirklin, James K. ;
Naftel, David C. ;
Pagani, Francis D. ;
Kormos, Robert L. ;
Stevenson, Lynne W. ;
Blume, Elizabeth D. ;
Myers, Susan L. ;
Miller, Marissa A. ;
Baldwin, J. Timothy ;
Young, James B. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (12) :1495-1504
[10]   Effectiveness and Safety of the Impella 5.0 as a Bridge to Cardiac Transplantation or Durable Left Ventricular Assist Device [J].
Lima, Brian ;
Kale, Parag ;
Gonzalez-Stawinski, Gonzalo V. ;
Kuiper, Johannes J. ;
Carey, Sandra ;
Hall, Shelley A. .
AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (10) :1622-1628